SHANGHAI – To tap into China’s fast-growing biopharmaceutical sector and explore opportunities for bringing new drugs to market, Germany-based Merck KGAA is providing tailor made support to small emerging biotech companies through a grant program and will consider possible growth partnerships.
Committed to helping advance life-saving drugs to market, Merck’s first emerging biotech grant program started in 2014, awarding NGM...